Advertisement

Quality of Life Research

, Volume 22, Issue 3, pp 585–596 | Cite as

A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting

  • Waguih William IsHakEmail author
  • Konstantin Balayan
  • Catherine Bresee
  • Jared Matt Greenberg
  • Hala Fakhry
  • Scott Christensen
  • Mark Hyman Rapaport
Article

Abstract

Purpose

Major depressive disorder (MDD) negatively impacts different aspects of an individual’s life leading to grave impairments in quality of life (QOL). We performed a detailed analysis of the interaction between depressive symptom severity, functioning, and QOL in outpatients with MDD in order to better understand QOL impairments in MDD.

Methods

This cross-sectional study was conducted with 319 consecutive outpatients seeking treatment for DSM-IV-diagnosed MDD at an urban hospital-based outpatient clinic from 2005 to 2008 as part of the Cedars-Sinai Psychiatric Treatment Outcome Registry, a prospective cohort study of clinical, functioning, and patient-reported QOL outcomes in psychiatric disorders using a measurement-based care model. This model utilizes the following measures: (a) Depressive symptom severity: Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR); (b) Functioning measures: Global Assessment of Functioning (GAF), Sheehan Disability Scale (SDS), Work and Social Adjustment Scale, and the Endicott Work Productivity Scale; and (c) Quality of Life measure: Quality of Life, Enjoyment, and Satisfaction Questionnaire—Short Form (Q-LES-Q).

Results

QOL is significantly impaired in MDD, with a mean Q-LES-Q score for this study population of 39.8 % (SD = 16.9), whereas the community norm average is 78.3 %. Regression modeling suggested that depressive symptom severity, functioning/disability, and age all significantly contributed to QOL. QIDS-SR (measuring depressive symptom severity), GAF, and SDS (measuring functioning/disability) scores accounted for 48.1, 17.4, and 13.3 % (semi-partial correlation values) of the variance in Q-LES-Q, respectively.

Conclusions

Our results show that impairment of QOL increases in a monotonic fashion with depressive symptom severity; however, depression symptom severity only accounted for 48.1 % of the QOL variance in our patient population. Furthermore, QOL is uniquely associated with measures of Functioning. We believe these results demonstrate the need to utilize not only Symptom Severity scales, but also Functioning and Quality of Life measures in MDD assessment, treatment, and research.

Keywords

Major depressive disorder Quality of life Major depression Health-related quality of life 

Abbreviations

BAI

Beck Anxiety Inventory

CS-PTR

Cedars-Sinai Psychiatric Treatment Outcome Registry

EWPS

Endicott Work Productivity Scale

GAF

Global Assessment of Functioning

IRB

Institutional Review Board

QIDS-SR

Quick Inventory of Depressive Symptomatology-Self Report

Q-LES-Q

Quality of Life, Enjoyment, and Satisfaction Questionnaire—Short Form

QOL

Quality of life

MDD

Major Depressive Disorder

SDS

Sheehan Disability Scale

WHO

World Health Organization

WSAS

Work and Social Adjustment Scale

Notes

Acknowledgments

The authors would like to thank the Cedars-Sinai Medical Center Psychiatry residents, trainees, staff, and faculty for their exceptional work with patients over the years, and for their contributions in building and maintaining the psychiatric treatment outcome registry cited in this work. The authors would also like to thank Ms. Gitta Morris for her exceptional help during the various stages of development of this manuscript. This research was supported by NARSAD Young Investigator Award Grant#CSMC215387 (Dr. IsHak) and by NIMH Grant#R01 MH073765 (Dr. Rapaport, Polier Endowed Chair in Schizophrenia and Related Disorders). Dr. IsHak received research support from NARSAD, Pfizer (ziprasidone monotherapy for major depression). Dr. Rapaport received research support from NIMH and NCCAM, and is an unpaid consultant for Pax Neuroscience.

Conflict of interest

Dr. Greenberg, Ms. Bresee, Dr. Balayan, Dr. Fakhry, and Mr. Christensen report no conflict of interest and have no relevant financial disclosure to report.

References

  1. 1.
    Constitution of the World Health Organization. (1946). American Journal of Public Health and the Nation’s Health, 36(11): 1315–1323.Google Scholar
  2. 2.
    Bonicatto, S. C., Dew, M. A., Zaratiegui, R., Lorenzo, L., & Pecina, P. (2001). Adult outpatients with depression: Worse quality of life than in other chronic medical diseases in Argentina. Social Science and Medicine, 52(6), 911–919.PubMedCrossRefGoogle Scholar
  3. 3.
    Papakostas, G. I., Petersen, T., Mahal, Y., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2004). Quality of life assessments in major depressive disorder: A review of the literature. General Hospital Psychiatry, 26, 13–17.PubMedCrossRefGoogle Scholar
  4. 4.
    Doraiswamy, P., Khan, Z. M., Donahue, J., & Richard, N. E. (2002). The spectrum of quality-of-life impairments in recurrent geriatric depression. Journal of Gerontology: Medical Sciences., 57A, M134–M137.CrossRefGoogle Scholar
  5. 5.
    Saarijarvi, S., Salminen, J. K., Toikka, T., & Raitasalo, R. (2002). Health-related quality of life among patients with major depression. Nordic Journal of Psychiatry, 56(4), 261–264.PubMedCrossRefGoogle Scholar
  6. 6.
    Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Warden, D., McKinney, W., Downing, M., et al. (2006). Factors associated with health-related quality of life among outpatients with major depressive disorder: A STAR*D report. Journal of Clinical Psychiatry, 67(2), 185–195.PubMedCrossRefGoogle Scholar
  7. 7.
    Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005). Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry, 162, 1171–1178.PubMedCrossRefGoogle Scholar
  8. 8.
    Rush, A. J., & Trivedi, M. H. (1995). Treating depression to remission. Psychiatric Annals, 25, 704–709.Google Scholar
  9. 9.
    Zimmerman, M., Mattia, J. I., & Posternak, M. A. (2002). Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? American Journal of Psychiatry, 159, 469–473.PubMedCrossRefGoogle Scholar
  10. 10.
    Angst, J., Kupfer, D. J., & Rosenbaum, J. F. (1996). Recovery from depression: Risk or reality? Acta Psychiatrica Scandinavica, 93, 413–419.PubMedCrossRefGoogle Scholar
  11. 11.
    Rapaport, M. H. (2009). Helping patients with depression achieve wellness. Journal of Clinical Psychiatry, 70(5), e11.PubMedCrossRefGoogle Scholar
  12. 12.
    Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33; quiz 34–57.Google Scholar
  13. 13.
    Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., et al. (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 585.CrossRefGoogle Scholar
  14. 14.
    Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.PubMedCrossRefGoogle Scholar
  15. 15.
    American Psychiatric Association. (1994). Global Assessment of Functioning in diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Publishing Inc.Google Scholar
  16. 16.
    Sheehan, D. V. (1983). The anxiety disease. New York, NY: Scribner’s.Google Scholar
  17. 17.
    Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. H. (2002). The Work and Social Adjustment Scale: A simple measure of impairment in functioning. British Journal of Psychiatry, 180, 461–464.PubMedCrossRefGoogle Scholar
  18. 18.
    Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacology Bulletin, 29, 321–326.PubMedGoogle Scholar
  19. 19.
    Schechter, D., Endicott, J., Nee, J. (2007). Quality of life of ‘normal’ controls: Association with lifetime history of mental illness. Psychiatry Research, 30 152(1):45–54.Google Scholar
  20. 20.
    Beck, A. T., & Steer, R. A. (1990). Beck Anxiety Inventory manual. San Antonio, TX: Psychological Corporation.Google Scholar
  21. 21.
    Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., et al. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. American Journal of Psychiatry, 165(3), 342–351.PubMedCrossRefGoogle Scholar
  22. 22.
    Reed, C., Monz, B. U., Perahia, D. G., Gandhi, P., Bauer, M., Dantchev, N., et al. (2009). Quality of life outcomes among patients with depression after 6 months of starting treatment: Results from FINDER. Journal of Affective Disorders, 113(3), 296–302.PubMedCrossRefGoogle Scholar
  23. 23.
    Fleck, M., Simon, G., & Herrman, H. (2005). Major Depression and its correlates in primary care settings in six countries. British Journal of Psychiatry, 186(1), 41–47.CrossRefGoogle Scholar
  24. 24.
    Wisniewski, S. R., Rush, A. J., Bryan, C., Shelton, R., Trivedi, M. H., Marcus, S., et al. (2007). Comparison of quality of life measures in a depressed population. Journal of Nervous and Mental Disease, 195(3), 219–225.PubMedCrossRefGoogle Scholar
  25. 25.
    Daly, E. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Gaynes, B. N., Warden, D., et al. (2010). Health-related quality of life in depression: A STAR*D report. Annals of Clinical Psychiatry, 22(1), 43–55.PubMedGoogle Scholar
  26. 26.
    Piccinelli, M., & Wilkinson, G. (2000). Gender differences in depression. Critical review. British Journal of Psychiatry, 177, 486–492.PubMedCrossRefGoogle Scholar
  27. 27.
    Fava, M., Alpert, J. E., Carmin, C. N., Wisniewski, S. R., Trivedi, M. H., Biggs, M. M., et al. (2004). Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine, 34(7), 1299–1308.PubMedCrossRefGoogle Scholar
  28. 28.
    Berlim, M. T., McGirr, A., & Fleck, M. P. (2008). Can sociodemographic and clinical variables predict the quality of life of outpatients with major depression? Psychiatry Research, 160(3), 364–371.PubMedCrossRefGoogle Scholar
  29. 29.
    da Rocha, N. S., Power, M. J., Bushnell, D. M., & Fleck, M. P. (2009). Is there a measurement overlap between depressive symptoms and quality of life? Comprehensive Psychiatry, 50(6), 549–555.PubMedCrossRefGoogle Scholar
  30. 30.
    Gureje, O., Kola, L., Afolabi, E., & Olley, B. O. (2008). Determinants of quality of life of elderly Nigerians: Results from the Ibadan study of ageing. African Journal of Medicine and Medical Sciences, 37(3), 239–247.PubMedGoogle Scholar
  31. 31.
    Moore, M., Hofer, S., McGee, H., & Ring, L. (2005). Can the concept of depression and quality of life be integrated using a time perspective? Health and Quality of Life Outcomes, 5, 3–11.Google Scholar
  32. 32.
    Ritsner, M. (2007). The distress/protection vulnerability model of quality of life impairment syndrome. In M. Ritsner & A. G. Awad (Eds.). Quality of life impairment in schizophrenia, mood, and anxiety disorders (pp. 3–19). The Netherlands: Springer.Google Scholar
  33. 33.
    Bech, P. (1995). Quality-of-life measurements for patients taking which drugs? The clinical PCASEE perspective. Pharmacoeconomics, 7(2), 141–151.PubMedCrossRefGoogle Scholar
  34. 34.
    Yen, C. F., Chen, C. C., Lee, Y., Tang, T. C., Ko, C. H., & Yen, J. Y. (2009). Association between quality of life and self-stigma, insight, and adverse effects of medication in patients with depressive disorders. Depression and Anxiety, 26(11), 1033–1039.PubMedCrossRefGoogle Scholar
  35. 35.
    Skevington, S. M., Lotfy, M., O’Connell, K. A., & WHOQOL Group. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13, 299–310.PubMedCrossRefGoogle Scholar
  36. 36.
    Kessler, R. C., Zhao, S., Blazer, D. G., & Swartz, M. (1997). Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. Journal of Affective Disorders, 45, 19–30.PubMedCrossRefGoogle Scholar
  37. 37.
    Maier, W., Gansicke, M., & Weiffenbach, O. (1997). The relationship between major and subthreshold variants of unipolar depression. Journal of Affective Disorders, 45, 41–51.PubMedCrossRefGoogle Scholar
  38. 38.
    IsHak, W. W., Greenberg, J. M., Balayan, K., Kapitanski, N., Jeffrey, J., Fathy, H., et al. (2011). Quality of life: The ultimate outcome measure of interventions in major depressive disorder. Harvard Review of Psychiatry, 19, 229–239.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Waguih William IsHak
    • 1
    • 2
    Email author
  • Konstantin Balayan
    • 3
  • Catherine Bresee
    • 4
  • Jared Matt Greenberg
    • 5
  • Hala Fakhry
    • 6
  • Scott Christensen
    • 3
  • Mark Hyman Rapaport
    • 7
  1. 1.Cedars-Sinai Medical CenterLos AngelesUSA
  2. 2.David Geffen School of Medicine at UCLALos AngelesUSA
  3. 3.Department of PsychiatryCedars-Sinai Medical CenterLos AngelesUSA
  4. 4.Samuel Oschin Comprehensive Cancer InstituteCedars-Sinai Medical CenterLos AngelesUSA
  5. 5.Department of Psychiatry and Biobehavioral ScienceDavid Geffen School of Medicine at UCLALos AngelesUSA
  6. 6.Department of Psychiatry, Faculty of MedicineCairo UniversityCairoEgypt
  7. 7.Department of Psychiatry and Behavioral SciencesEmory University School of MedicineAtlantaUSA

Personalised recommendations